CBB-23273-76297
3 vaccinations
8 coded responses
11 check-ins
7 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 234 / VA
- Registered
- 2022-07-19
- Relationship
- Child or adolescent in my care
- Guardian
- ESN-18128-50422
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-29
Dose 1 — Pfizer-BioNTech
-
2021-07-20
Dose 2 — Pfizer-BioNTech
-
2022-07-15
Dose 3 — Pfizer-BioNTech
-
2022-07-19
Registered in v-safe
-
2022-07-19
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Emergency care, Hospitalisation, Intensive care, Myocarditis, Pericarditis — Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Pericarditis and myocarditis requiring emergency care, pediatric ICU admission, and associated cardiology evaluations and treatmentsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-19
Report sent to call center — days 1–6 daily, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-07-20
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Chest pain, Implantable cardiac monitor insertion, Myocarditis, Pericarditis — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Myocarditis/Pericarditis chest pain · Healthcare visit (other): Repeat 12-lead ECG, troponin lab check, continuous cardiac monitoring device placementMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — days 1–6 daily, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-20
-
2022-07-21
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-07-21
- 2022-07-21
-
2022-07-21
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-07-22
Survey response — day 7, dose 3, dependentMedDRA: Troponin increased, Unevaluable event — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Troponin increased. If elevated tomorrow, need IVIG. · Healthcare visit (other): Labs, 12 lead EKG, echocardiogramMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Report sent to call center — day 7, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-25
- 2022-07-27
-
2022-07-31
Survey response — day 14, dose 3, dependentMedDRA: Hospitalisation, Intensive care, Myopericarditis, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Readmitted to peds ICU last weekend for IVIG infusion due to worsening perimyocarditis. Discharged home, then readmitted to inpatient peds ward due to IVIG adverse reaction. Reevaluated in peds clinic after peds ward discharge.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-31
Report sent to call center — day 14, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-08-05
- 2022-08-05
- 2022-08-05
- 2022-08-05
- 2022-08-05
-
2022-08-12
Survey response — day 28, dose 3, dependentMedDRA: Tachycardia, Telemedicine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Continued tachycardia episodes at rest and with activity. Cardiac MRI results received and are normal. · Healthcare visit (other): Telehealth with pediatric cardiologistMedDRA releases: 2024-11 · check-in free text available
-
2022-08-12
Report sent to call center — day 28, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-12
-
2022-08-12
Callback requested for01:00PM ET
- 2022-08-12
-
2022-08-12
Callback requested for01:00PM ET
- 2022-08-12
-
2022-08-21
Survey response — day 35, dose 3, dependentMedDRA: Chest pain, Dizziness, Tachycardia, Troponin increased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Troponin significantly more elevated. Reoccurrence or chest pain. Tachycardia episodes up to 140s. Dizziness.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-21
Report sent to call center — day 35, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-22
- 2022-08-22
- 2022-08-22
- 2022-08-22
- 2022-08-22
- 2022-08-22
-
2022-08-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-28
Survey response — day 42, dose 3, dependentMedDRA: Dizziness, Fatigue, Presyncope, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Persistent fatigue and continued tachycardia episodes, sometimes associated with dizziness and pre-syncope symptoms. Additional labs have been drawn to check for possible new high dose IVIG adverse effects.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-28
Report sent to call center — day 42, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-30
- 2022-10-14
-
2023-01-13
Survey response — 6 months, dose 3, dependentMedDRA: Cardiac disorder, Cognitive disorder, Physiotherapy, Vestibular disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-13
Report sent to call center — 6 months, dose 3, dependentBe unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-16
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-29 | Pfizer-BioNTech | No |
| 2 | 2021-07-20 | Pfizer-BioNTech | No |
| 3 | 2022-07-15 | Pfizer-BioNTech | No |
Call center
8 call center cases
6 successful · 2 unsuccessful
VAERS report filed, before or during a call: 7
Free text
Release 12 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Pericarditis and myocarditis requiring emergency care, pediatric ICU admission, and associated cardiology evaluations and treatments
Systemic reaction (other): Myocarditis/Pericarditis chest pain
Healthcare visit (other): Repeat 12-lead ECG, troponin lab check, continuous cardiac monitoring device placement
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Troponin increased. If elevated tomorrow, need IVIG.
Healthcare visit (other): Labs, 12 lead EKG, echocardiogram
Release 12 — day 14, dose 3, dependent
Symptoms: Readmitted to peds ICU last weekend for IVIG infusion due to worsening perimyocarditis. Discharged home, then readmitted to inpatient peds ward due to IVIG adverse reaction. Reevaluated in peds clinic after peds ward discharge.
Release 12 — day 28, dose 3, dependent
Symptoms: Continued tachycardia episodes at rest and with activity. Cardiac MRI results received and are normal.
Healthcare visit (other): Telehealth with pediatric cardiologist
Release 12 — day 35, dose 3, dependent
Symptoms: Troponin significantly more elevated. Reoccurrence or chest pain. Tachycardia episodes up to 140s. Dizziness.
Release 12 — day 42, dose 3, dependent
Symptoms: Persistent fatigue and continued tachycardia episodes, sometimes associated with dizziness and pre-syncope symptoms. Additional labs have been drawn to check for possible new high dose IVIG adverse effects.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Implantable cardiac monitor insertion | · | · | ✓ |
| HCVO | Telemedicine | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Cardiac disorder | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Intensive care | · | · | ✓ |
| SD | Myopericarditis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Physiotherapy | · | · | ✓ |
| SD | Presyncope | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Troponin increased | · | · | ✓ |
| SD | Vestibular disorder | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Emergency care | · | · | ✓ |
| SRO | Hospitalisation | · | · | ✓ |
| SRO | Intensive care | · | · | ✓ |
| SRO | Myocarditis | · | · | ✓ |
| SRO | Pericarditis | · | · | ✓ |
| SRO | Troponin increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release